Peer-Reviewed Publications

CPCE investigators are international experts in their clinical effectiveness-related fields, and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here you can access CPCE journal article abstracts by author, title, or year.

Found 1465 results
Author [ Title(Desc)] Year
Filters: First Letter Of Last Name is L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Mathieu I, Wallis K, Japa I, et al. "Caregiver Strengths, Attitudes, and Concerns About Reading and Child Development in the Dominican Republic." Glob Pediatr Health. 2020;7:2333794X20942661.
Williamson AA, Leichman ES, Walters RM, Mindell JA. "Caregiver-perceived sleep outcomes in toddlers sleeping in cribs versus beds." Sleep Med.. 2019;54:16-21.
Magrini D, Li SC, Bhise V, Weiss PF, Moorthy LN. "Case 1: Alopecia in a Healthy 9-year-old Girl." Pediatr Rev. 2015;36(11):503-5.
Scheetz MH, Lodise TP, Downes KJ, Drusano G, Neely M. "The case for precision dosing: medical conservatism does not justify inaction." J Antimicrob Chemother. 2021.
Lindell RB, Wolf MS, Alcamo AM, et al. "Case Report: Immune Dysregulation Due to Reactivation After Allogeneic Hematopoietic Cell Transplant." Front Pediatr. 2021;9:719679.
Mitchell HK, Mokomane M, Leeme T, et al. "Causes of Pediatric Meningitis in Botswana: Results From a 16-Year National Meningitis Audit." Pediatr. Infect. Dis. J.. 2019.
Huang BJ, Smith J, Wang J, et al. "CBFB-MYH11 Fusion Transcripts Distinguish Acute Myeloid Leukemias with Distinct Molecular Landscapes and Outcomes." Blood Adv. 2021.
Huang BJ, Smith J, Wang J, et al. "CBFB-MYH11 Fusion Transcripts Distinguish Acute Myeloid Leukemias with Distinct Molecular Landscapes and Outcomes." Blood Adv. 2021.
Lamble AJ, Brodersen LEidenschin, Alonzo TA, et al. "CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group." J Clin Oncol. 2021:JCO2101595.
Lamble AJ, Brodersen LEidenschin, Alonzo TA, et al. "CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group." J Clin Oncol. 2021:JCO2101595.
Leahy ABarz, Newman H, Li Y, et al. "CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials." Lancet Haematol. 2021;8(10):e711-e722.
Leahy ABarz, Newman H, Li Y, et al. "CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials." Lancet Haematol. 2021;8(10):e711-e722.
Leahy ABarz, Newman H, Li Y, et al. "CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials." Lancet Haematol. 2021;8(10):e711-e722.
Pollard JA, Loken MR, Gerbing RB, et al. "CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531." J. Clin. Oncol.. 2016;34(7):747-55.
Lamba JK, Chauhan L, Shin M, et al. "CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531." J. Clin. Oncol.. 2017:JCO2016712513.
Lamba JK, Chauhan L, Shin M, et al. "CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children's Oncology Group Trial AAML0531." J. Clin. Oncol.. 2017:JCO2016712513.
Lamba JK, Voigt AP, Chauhan L, et al. "CD33 splicing SNP regulates expression levels of CD33 in normal regenerating monocytes in AML patients." Leuk. Lymphoma. 2018:1-4.
Lamba JK, Voigt AP, Chauhan L, et al. "CD33 splicing SNP regulates expression levels of CD33 in normal regenerating monocytes in AML patients." Leuk. Lymphoma. 2018:1-4.
Tarlock K, Lamble A, Wang J, et al. "CEBPA bZip Mutations are Associated with Favorable Prognosis in de novo AML: A Report from the Children's Oncology Group." Blood. 2021.
Tarlock K, Lamble A, Wang J, et al. "CEBPA bZip Mutations are Associated with Favorable Prognosis in de novo AML: A Report from the Children's Oncology Group." Blood. 2021.
Tarlock K, Lamble A, Wang J, et al. "CEBPA bZip Mutations are Associated with Favorable Prognosis in de novo AML: A Report from the Children's Oncology Group." Blood. 2021.
O'Connor MJ, Zhang X, Griffis H, et al. "Center Variation in Indication and Short-Term Outcomes after Pediatric Heart Transplantation: Analysis of a Merged United Network for Organ Sharing - Pediatric Health Information System Cohort." Pediatr Cardiol. 2021.
O'Connor MJ, Zhang X, Griffis H, et al. "Center Variation in Indication and Short-Term Outcomes after Pediatric Heart Transplantation: Analysis of a Merged United Network for Organ Sharing - Pediatric Health Information System Cohort." Pediatr Cardiol. 2021.
Miller TP, Li Y, Kavcic M, et al. "Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: A report from the Children's Oncology Group." Haematologica. 2017.
Miller TP, Li Y, Kavcic M, et al. "Center-level variation in accuracy of adverse event reporting in a clinical trial for pediatric acute myeloid leukemia: A report from the Children's Oncology Group." Haematologica. 2017.

Pages